Table 3.
The Criterion validity of the HIV Meditation Taking Self-Efficacy Scale (HIV MT SES)
HIV medication-taking self-efficacy (0 week) |
|||
---|---|---|---|
Overall scale | Self-efficacy beliefs: SEB |
Outcome expectancy: OE |
|
SEB at baseline | .91*** | - | - |
OE at baseline | .68*** | .37*** | - |
| |||
Overall scale (12wk) | .66*** | .52*** | .52*** |
SEB at 12wk | .58*** | .55*** | .32** |
OE at 12wk | .54*** | .30** | .66*** |
| |||
Energy/fatigue | .38*** | .28*** | .37*** |
Mental Health | .38*** | .29*** | .37*** |
Complexity of medication regimen† | −.20** | −.18** | −.16** |
Impact of side effects † | −.29*** | −.24*** | −.40*** |
Social Support | .35*** | .27*** | .37*** |
Self-report medication-taking (baseline) | .58*** | .61*** | .24*** |
Self-report medication-taking (12wk)‡ | .41*** | .43*** | .14* |
p <.05
p<.01
p<.001
indicates discriminate validity of HIV MT SES
indicates predictive validity of the HIV MT SES